Effect of liraglutide on cardiovascular events in patients with type 2 diabetes mellitus and polyvascular disease results of the LEADER trial

LEADER Publication Committee on behalf of the LEADER Trial Investigators

Research output: Contribution to journalArticle

28 Scopus citations
Original languageEnglish (US)
Pages (from-to)2179-2183
Number of pages5
JournalCirculation
Volume137
Issue number20
DOIs
StatePublished - 2018

Keywords

  • Atherosclerosis
  • Diabetes mellitus
  • Glucagon-like peptide 1
  • Liraglutide
  • Myocardial infarction
  • Type 2

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this